IP Library Granted Patent US 9,011,838
Granted Patent B2
US 9,011,838 · App. 12/763,775 · Granted Apr 21, 2015

Low/high dose probiotic supplements and methods of their use

Inventors: Douglas Ware (Chapel Hill, NC); Peter Anderson (Leawood, KS)
Assignee: Nutrition Physiology Company, LLC
A61K35/74A61K38/47A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,011,838
App. No.
12/763,775
Granted
Apr 21, 2015
Kind
B2
Abstract

Methods and compositions are hereby disclosed for reducing the numbers of E. coli O157:H7, Salmonella or other pathogens in an animal. The methods include administering to the animal a lactic acid producing bacterium at a relatively low dosage in combination with a lactate utilizing bacterium, followed by administration of the lactic acid producing bacterium at a relatively high dosage. The disclosed methods help achieve pre-harvest food safety and enhance feed performance while keeping the total cost relatively low. The preferred lactic acid producing bacterium is Lactobacillus acidophilus/animalis and the preferred lactate utilizing bacterium is Propionibacterium freudenreichii.

Claims (22)

1. A method for reducing the numbers of pathogens and/or for enhancing feed efficiency in cattle, said method comprising:

(a) administering to said cattle at least one lactic acid producing bacterium for at least 30 days, wherein said lactic acid producing bacterium is administered to said cattle at a dosage of between 1×10 5 and 5×10 7 colony forming units (CFU) per day; and

(b) administering to said cattle at least one lactic acid producing bacterium for at least 20 days, wherein said lactic acid producing bacterium is administered to said cattle at a dosage of between 5×10 8 and 5×10 9 CFU per day,

wherein step (a) precedes step (b), said step (a) being started 120-360 days prior to harvesting said cattle and continued to 20-60 days prior to harvesting, wherein the time period between end of step (a) and start of step (b) is from 0 to 10 days.

2. The method of claim 1 , wherein said at least one lactic acid producing bacterium is a strain selected from the group consisting of C28, LA45, LA51 and L411 strains.

3. The method of claim 2 , wherein the strain is the LA51 strain.

4. The method of claim 1 , wherein step (b) is performed for 20-60 days.

5. The method of claim 1 , wherein the administration of said at least one lactic acid producing bacterium in step (a) or (b) is performed continuously on a daily basis.

6. The method of claim 1 , wherein said lactic acid producing bacterium is administered in step (a) to said cattle at a dosage of between 8×10 6 and 2×10 7 CFU per day.

7. The method of claim 1 , wherein said lactic acid producing bacterium is administered in step (b) to said cattle at a dosage of between 8×10 8 and 2×10 9 CFU per day.

8. The method of claim 1 , wherein both steps (a) and (b) further comprise administering to said cattle at least one lactate utilizing bacterium, wherein said step (a) comprises administering to said cattle at least one lactic acid producing bacterium and at least one lactate utilizing bacterium for at least 30 days, said lactic acid producing bacterium being administered to said cattle at a dosage of between 1×10 6 and 5×10 7 CFU per day, and said lactate utilizing bacterium being administered to said cattle at a dosage of between 5×10 8 and 5×10 9 CFU per day; and

wherein said step (b) comprises administering to said cattle at least one lactic acid producing bacterium and at least one lactate utilizing bacterium for at least 20 days, said lactic acid producing bacterium being administered to said cattle at a dosage of between 5×10 8 and 5×10 9 CFU per day, and said lactate utilizing bacterium being administered to said cattle at a dosage of between 5×10 8 and 5×10 9 CFU per day,

wherein step (a) precedes step (b), and said at least one lactic acid producing bacterium is a strain selected from the group consisting of C28, LA45, LA51 and L411 strains, and said at least one lactate utilizing bacterium is a Propionibacterium freudenreichii strain selected from the group consisting of P9, PF24, P42, P93 and P99 strains.

9. The method of claim 1 , wherein said step (a) further comprises administering to said cattle at least one lactate utilizing bacterium for at least 30 days, wherein said lactate utilizing bacterium is administered to said cattle at a dosage of between 5×10 8 and 5×10 9 CFU per day; and

wherein said step (b) further comprises administering to said cattle at least one lactate utilizing bacterium for at least 20 days, wherein said lactate utilizing bacterium is administered to said cattle at a dosage of between 5×10 8 and 5×10 9 CFU per day.

10. The method of claim 9 , wherein said at least one lactic acid producing bacterium is a Lactobacillus acidophilus/animalis strain selected from the group consisting of C28, M35, LA45, LA51 and L411 strains.

11. The method of claim 9 , wherein the pathogen is selected from the group consisting of Escherichia coli, Salmonella spp., and Staphylococcus aureus.

12. The method of claim 9 , wherein said lactic acid producing bacterium is administered in step (a) to said cattle at a dosage of about 1×10 7 CFU per day.

13. The method of claim 9 , wherein said lactic acid producing bacterium is administered in step (b) to said cattle at a dosage of about 1×10 9 CFU per day.

14. The method of claim 9 , wherein said lactate utilizing bacterium is administered in steps (a) and (b) to said animal cattle at a dosage of between 8×10 8 and 2×10 9 CFU per day.

15. The method of claim 9 , wherein said lactate utilizing bacterium is administered in steps (a) and (b) to said cattle at a dosage of about 1×10 9 CFU per day.

16. The method of claim 9 , wherein the administration in step (a) or step (b) is performed discontinuously.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2016
From: NUTRITION PHYSIOLOGY COMPANY, LLC
To: CHR. HANSEN A/S
Reel/Frame 038287/0072 →
SECURITY AGREEMENT Recorded Jul 19, 2012
From: NUTRITION PHYSIOLOGY COMPANY, LLC
To: FIFTH THIRD BANK
Reel/Frame 028597/0811 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2011
From: WARE, DOUGLAS R.; ANDERSON, PETER
To: NUTRITION PHYSIOLOGY COMPANY, LLC
Reel/Frame 026259/0384 →
Continuity (1)
Related Publication 20110256116A1 · Oct 20, 2011